BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.
BioLamina has raised $18.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
BioLamina's investors include Lauxera Capital Partners, Northislet, Bure Equity AB.
BioLamina is headquartered in Sundbyberg, Sweden.
BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.
BioLamina is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioLamina — Funding & Investors." VCBacked, September 12, 2023, https://www.vcbacked.co/company/biolamina. Accessed July 20, 2026.
VCBacked. (2023). BioLamina — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/biolamina
{{cite web |title=BioLamina — Funding & Investors |url=https://www.vcbacked.co/company/biolamina |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated